ArticleJournal of Cancer2024

Lnc-CLSTN2-1:1 Promotes Osteosarcoma Progression by Disrupting Redox Balance through PI3K/AKT Signaling Pathway.

Hao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.